BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Panayiotakopoulos GD, Papadimitriou DT. Rifampicin for COVID-19. World J Virol 2022; 11(2): 90-97 [PMID: 35433334 DOI: 10.5501/wjv.v11.i2.90]
URL: https://www.wjgnet.com/1007-9327/full/v11/i2/90.htm
Number Citing Articles
1
Marwa El-Azazy, Ahmed S. El-Shafie, Reem Al-Mulla, Siham S. Hassan, Hassan I. Nimir. Enhanced adsorptive removal of rifampicin and tigecycline from single system using nano-ceria decorated biochar of mango seed kernelHeliyon 2023; 9(5): e15802 doi: 10.1016/j.heliyon.2023.e15802
2
Ozlem Celik Aydin, Sonay Aydın, Sureyya Barun. Possible agent for COVID-19 treatment: RifampicinWorld Journal of Virology 2022; 11(5): 391-393 doi: 10.5501/wjv.v11.i5.391
3
Bhoomika Patel, Anita Sinha, Mamatarani Verma, Dhwani Patel, Jigar Desai. A Study of COVID-19 Infected Patients with Tuberculosis as Comorbidity and on Antitubercular Drug TherapyIndian Journal of Respiratory Care 2023; 12(3): 239 doi: 10.5005/jp-journals-11010-1058
4
Jasmine Arya, Sweety Dahiya, Anil Kumar Chhillar. Multidrug-resistant Tuberculosis and its Implication with COVID-19Coronaviruses 2023; 4(3) doi: 10.2174/2666796704666230822113632